Impact of Enhanced Recovery after Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge from the Hospital: A Historical-Prospective Study

Delara Brandal, Michelle S. Keller, Carol Lee, Tristan Grogan, Yohei Fujimoto, Yann Gricourt, Takashige Yamada, Siamak Rahman, Ira Hofer, Kevork Kazanjian, Jonathan Sack, Aman Mahajan, Anne Lin, Maxime Cannesson

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

BACKGROUND: The United States is in the midst of an opioid epidemic, and opioid use disorder often begins with a prescription for acute pain. The perioperative period represents an important opportunity to prevent chronic opioid use, and recently there has been a paradigm shift toward implementation of enhanced recovery after surgery (ERAS) protocols that promote opioid-free and multimodal analgesia. The objective of this study was to assess the impact of an ERAS intervention for colorectal surgery on discharge opioid prescribing practices. METHODS: We conducted a historical-prospective quality improvement study of an ERAS protocol implemented for patients undergoing colorectal surgery with a focus on the opioid-free and multimodal analgesia components of the pathway. We compared patients undergoing colorectal surgery 1 year before implementation (June 15, 2015, to June 14, 2016) and 1 year after implementation (June 15, 2016, to June 14, 2017). RESULTS: Before the ERAS intervention, opioids at discharge were not significantly increasing (1% per month; 95% confidence interval [CI],-1% to 3%; P =.199). Immediately after the ERAS intervention, opioid prescriptions were not significantly lower (13%; 95% CI,-30% to 3%; P =.110). After the intervention, the rate of opioid prescriptions at discharge did not decrease significantly 1% (95% CI,-3% to 1%) compared to the pre-period rate (P =.399). Subgroup analysis showed that in patients with a combination of low discharge pain scores, no preoperative opioid use, and low morphine milligram equivalents consumption before discharge, the rate of discharge opioid prescription was 72% (95% CI, 61%-83%). CONCLUSIONS: This study is the first to report discharge opioid prescribing practices in an ERAS setting. Although an ERAS intervention for colorectal surgery led to an increase in opioid-free anesthesia and multimodal analgesia, we did not observe an impact on discharge opioid prescribing practices. The majority of patients were discharged with an opioid prescription, including those with a combination of low discharge pain scores, no preoperative opioid use, and low morphine milligram equivalents consumption before discharge. This observation in the setting of an ERAS pathway that promotes multimodal analgesia suggests that our findings are very likely to also be observed in non-ERAS settings and offers an opportunity to modify opioid prescribing practices on discharge after surgery. For opioid-free anesthesia and multimodal analgesia to influence the opioid epidemic, the dose and quantity of the opioids prescribed should be modified based on the information gathered by in-hospital pain scores and opioid use as well as pain history before admission.

Original languageEnglish
Pages (from-to)1784-1792
Number of pages9
JournalAnesthesia and Analgesia
Volume125
Issue number5
DOIs
Publication statusPublished - 2017 Nov 1

Fingerprint

Opioid Analgesics
Prescriptions
Anesthesia
Prospective Studies
Colorectal Surgery
Confidence Intervals
Analgesia
Anesthesia and Analgesia
Pain
Morphine
Perioperative Period
Acute Pain
Quality Improvement

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Impact of Enhanced Recovery after Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge from the Hospital : A Historical-Prospective Study. / Brandal, Delara; Keller, Michelle S.; Lee, Carol; Grogan, Tristan; Fujimoto, Yohei; Gricourt, Yann; Yamada, Takashige; Rahman, Siamak; Hofer, Ira; Kazanjian, Kevork; Sack, Jonathan; Mahajan, Aman; Lin, Anne; Cannesson, Maxime.

In: Anesthesia and Analgesia, Vol. 125, No. 5, 01.11.2017, p. 1784-1792.

Research output: Contribution to journalReview article

Brandal, D, Keller, MS, Lee, C, Grogan, T, Fujimoto, Y, Gricourt, Y, Yamada, T, Rahman, S, Hofer, I, Kazanjian, K, Sack, J, Mahajan, A, Lin, A & Cannesson, M 2017, 'Impact of Enhanced Recovery after Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge from the Hospital: A Historical-Prospective Study', Anesthesia and Analgesia, vol. 125, no. 5, pp. 1784-1792. https://doi.org/10.1213/ANE.0000000000002510
Brandal, Delara ; Keller, Michelle S. ; Lee, Carol ; Grogan, Tristan ; Fujimoto, Yohei ; Gricourt, Yann ; Yamada, Takashige ; Rahman, Siamak ; Hofer, Ira ; Kazanjian, Kevork ; Sack, Jonathan ; Mahajan, Aman ; Lin, Anne ; Cannesson, Maxime. / Impact of Enhanced Recovery after Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge from the Hospital : A Historical-Prospective Study. In: Anesthesia and Analgesia. 2017 ; Vol. 125, No. 5. pp. 1784-1792.
@article{8e593b1a504c4e30b0dab5d2f2fdbb28,
title = "Impact of Enhanced Recovery after Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge from the Hospital: A Historical-Prospective Study",
abstract = "BACKGROUND: The United States is in the midst of an opioid epidemic, and opioid use disorder often begins with a prescription for acute pain. The perioperative period represents an important opportunity to prevent chronic opioid use, and recently there has been a paradigm shift toward implementation of enhanced recovery after surgery (ERAS) protocols that promote opioid-free and multimodal analgesia. The objective of this study was to assess the impact of an ERAS intervention for colorectal surgery on discharge opioid prescribing practices. METHODS: We conducted a historical-prospective quality improvement study of an ERAS protocol implemented for patients undergoing colorectal surgery with a focus on the opioid-free and multimodal analgesia components of the pathway. We compared patients undergoing colorectal surgery 1 year before implementation (June 15, 2015, to June 14, 2016) and 1 year after implementation (June 15, 2016, to June 14, 2017). RESULTS: Before the ERAS intervention, opioids at discharge were not significantly increasing (1{\%} per month; 95{\%} confidence interval [CI],-1{\%} to 3{\%}; P =.199). Immediately after the ERAS intervention, opioid prescriptions were not significantly lower (13{\%}; 95{\%} CI,-30{\%} to 3{\%}; P =.110). After the intervention, the rate of opioid prescriptions at discharge did not decrease significantly 1{\%} (95{\%} CI,-3{\%} to 1{\%}) compared to the pre-period rate (P =.399). Subgroup analysis showed that in patients with a combination of low discharge pain scores, no preoperative opioid use, and low morphine milligram equivalents consumption before discharge, the rate of discharge opioid prescription was 72{\%} (95{\%} CI, 61{\%}-83{\%}). CONCLUSIONS: This study is the first to report discharge opioid prescribing practices in an ERAS setting. Although an ERAS intervention for colorectal surgery led to an increase in opioid-free anesthesia and multimodal analgesia, we did not observe an impact on discharge opioid prescribing practices. The majority of patients were discharged with an opioid prescription, including those with a combination of low discharge pain scores, no preoperative opioid use, and low morphine milligram equivalents consumption before discharge. This observation in the setting of an ERAS pathway that promotes multimodal analgesia suggests that our findings are very likely to also be observed in non-ERAS settings and offers an opportunity to modify opioid prescribing practices on discharge after surgery. For opioid-free anesthesia and multimodal analgesia to influence the opioid epidemic, the dose and quantity of the opioids prescribed should be modified based on the information gathered by in-hospital pain scores and opioid use as well as pain history before admission.",
author = "Delara Brandal and Keller, {Michelle S.} and Carol Lee and Tristan Grogan and Yohei Fujimoto and Yann Gricourt and Takashige Yamada and Siamak Rahman and Ira Hofer and Kevork Kazanjian and Jonathan Sack and Aman Mahajan and Anne Lin and Maxime Cannesson",
year = "2017",
month = "11",
day = "1",
doi = "10.1213/ANE.0000000000002510",
language = "English",
volume = "125",
pages = "1784--1792",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Impact of Enhanced Recovery after Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge from the Hospital

T2 - A Historical-Prospective Study

AU - Brandal, Delara

AU - Keller, Michelle S.

AU - Lee, Carol

AU - Grogan, Tristan

AU - Fujimoto, Yohei

AU - Gricourt, Yann

AU - Yamada, Takashige

AU - Rahman, Siamak

AU - Hofer, Ira

AU - Kazanjian, Kevork

AU - Sack, Jonathan

AU - Mahajan, Aman

AU - Lin, Anne

AU - Cannesson, Maxime

PY - 2017/11/1

Y1 - 2017/11/1

N2 - BACKGROUND: The United States is in the midst of an opioid epidemic, and opioid use disorder often begins with a prescription for acute pain. The perioperative period represents an important opportunity to prevent chronic opioid use, and recently there has been a paradigm shift toward implementation of enhanced recovery after surgery (ERAS) protocols that promote opioid-free and multimodal analgesia. The objective of this study was to assess the impact of an ERAS intervention for colorectal surgery on discharge opioid prescribing practices. METHODS: We conducted a historical-prospective quality improvement study of an ERAS protocol implemented for patients undergoing colorectal surgery with a focus on the opioid-free and multimodal analgesia components of the pathway. We compared patients undergoing colorectal surgery 1 year before implementation (June 15, 2015, to June 14, 2016) and 1 year after implementation (June 15, 2016, to June 14, 2017). RESULTS: Before the ERAS intervention, opioids at discharge were not significantly increasing (1% per month; 95% confidence interval [CI],-1% to 3%; P =.199). Immediately after the ERAS intervention, opioid prescriptions were not significantly lower (13%; 95% CI,-30% to 3%; P =.110). After the intervention, the rate of opioid prescriptions at discharge did not decrease significantly 1% (95% CI,-3% to 1%) compared to the pre-period rate (P =.399). Subgroup analysis showed that in patients with a combination of low discharge pain scores, no preoperative opioid use, and low morphine milligram equivalents consumption before discharge, the rate of discharge opioid prescription was 72% (95% CI, 61%-83%). CONCLUSIONS: This study is the first to report discharge opioid prescribing practices in an ERAS setting. Although an ERAS intervention for colorectal surgery led to an increase in opioid-free anesthesia and multimodal analgesia, we did not observe an impact on discharge opioid prescribing practices. The majority of patients were discharged with an opioid prescription, including those with a combination of low discharge pain scores, no preoperative opioid use, and low morphine milligram equivalents consumption before discharge. This observation in the setting of an ERAS pathway that promotes multimodal analgesia suggests that our findings are very likely to also be observed in non-ERAS settings and offers an opportunity to modify opioid prescribing practices on discharge after surgery. For opioid-free anesthesia and multimodal analgesia to influence the opioid epidemic, the dose and quantity of the opioids prescribed should be modified based on the information gathered by in-hospital pain scores and opioid use as well as pain history before admission.

AB - BACKGROUND: The United States is in the midst of an opioid epidemic, and opioid use disorder often begins with a prescription for acute pain. The perioperative period represents an important opportunity to prevent chronic opioid use, and recently there has been a paradigm shift toward implementation of enhanced recovery after surgery (ERAS) protocols that promote opioid-free and multimodal analgesia. The objective of this study was to assess the impact of an ERAS intervention for colorectal surgery on discharge opioid prescribing practices. METHODS: We conducted a historical-prospective quality improvement study of an ERAS protocol implemented for patients undergoing colorectal surgery with a focus on the opioid-free and multimodal analgesia components of the pathway. We compared patients undergoing colorectal surgery 1 year before implementation (June 15, 2015, to June 14, 2016) and 1 year after implementation (June 15, 2016, to June 14, 2017). RESULTS: Before the ERAS intervention, opioids at discharge were not significantly increasing (1% per month; 95% confidence interval [CI],-1% to 3%; P =.199). Immediately after the ERAS intervention, opioid prescriptions were not significantly lower (13%; 95% CI,-30% to 3%; P =.110). After the intervention, the rate of opioid prescriptions at discharge did not decrease significantly 1% (95% CI,-3% to 1%) compared to the pre-period rate (P =.399). Subgroup analysis showed that in patients with a combination of low discharge pain scores, no preoperative opioid use, and low morphine milligram equivalents consumption before discharge, the rate of discharge opioid prescription was 72% (95% CI, 61%-83%). CONCLUSIONS: This study is the first to report discharge opioid prescribing practices in an ERAS setting. Although an ERAS intervention for colorectal surgery led to an increase in opioid-free anesthesia and multimodal analgesia, we did not observe an impact on discharge opioid prescribing practices. The majority of patients were discharged with an opioid prescription, including those with a combination of low discharge pain scores, no preoperative opioid use, and low morphine milligram equivalents consumption before discharge. This observation in the setting of an ERAS pathway that promotes multimodal analgesia suggests that our findings are very likely to also be observed in non-ERAS settings and offers an opportunity to modify opioid prescribing practices on discharge after surgery. For opioid-free anesthesia and multimodal analgesia to influence the opioid epidemic, the dose and quantity of the opioids prescribed should be modified based on the information gathered by in-hospital pain scores and opioid use as well as pain history before admission.

UR - http://www.scopus.com/inward/record.url?scp=85032452777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032452777&partnerID=8YFLogxK

U2 - 10.1213/ANE.0000000000002510

DO - 10.1213/ANE.0000000000002510

M3 - Review article

C2 - 29049123

AN - SCOPUS:85032452777

VL - 125

SP - 1784

EP - 1792

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 5

ER -